Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019901

Expand all

ALTACE (RAMIPRIL)
1.25MG Marketing Status: Prescription

Active Ingredient: RAMIPRIL
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 1.25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 001
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

ALTACE (RAMIPRIL)
2.5MG Marketing Status: Prescription

Active Ingredient: RAMIPRIL
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 2.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 002
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

ALTACE (RAMIPRIL)
5MG Marketing Status: Prescription

Active Ingredient: RAMIPRIL
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 003
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

ALTACE (RAMIPRIL)
10MG Marketing Status: Prescription

Active Ingredient: RAMIPRIL
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N019901
Product Number: 004
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English